Targeting Meningeal Lymphatic Vessels to Advance Stroke Therapy

Yang Liu1,2, Xiansheng Liu3,4, Shihao Lin3

  • 1Department of Neurology, Tongren City People's Hospital, Tongren, Guizhou, China.

Aging and Disease
|May 1, 2026
PubMed

Insights

Meningeal lymphatic vessels (mLVs) are crucial for brain health. Stroke impairs mLVs, worsening brain injury and cognitive decline, highlighting potential therapeutic targets.

Area of Science:

  • Neuroscience
  • Immunology
  • Vascular Biology

Background:

  • Meningeal lymphatic vessels (mLVs) are key to central nervous system (CNS) homeostasis, managing cerebrospinal fluid (CSF) drainage, waste clearance, and immune surveillance.
  • Stroke significantly disrupts mLV function, exacerbating edema and neuroinflammation, and contributing to long-term cognitive deficits.

Purpose of the Study:

  • To review the anatomy, physiology, and dynamic remodeling of mLVs post-stroke.
  • To examine the immune roles of mLVs in brain injury and repair after stroke.
  • To discuss therapeutic strategies targeting the glymphatic-lymphatic axis for stroke treatment.

Main Methods:

  • Literature review synthesizing current understanding of mLVs in stroke.
  • Analysis of preclinical models and available human data on mLV function after stroke.

Main Results:

  • mLVs undergo significant remodeling following stroke, impairing crucial clearance pathways.
  • Dysfunctional mLVs contribute to acute brain injury and chronic post-stroke cognitive impairment.
  • Emerging therapies targeting the glymphatic-lymphatic axis show promise but require clinical validation.

Conclusions:

  • Impaired mLV function is implicated in stroke pathophysiology, affecting fluid clearance and brain repair.
  • Current mechanistic insights are largely from preclinical studies, necessitating caution in clinical application.
  • Further research and rigorous clinical validation are essential for translating findings into effective stroke therapies.

Related Concept Videos